appropriate editor (contact information is further down this page) or let us know at dpo@denverpost.com or newsroom@denverpost.com Submit an event to The Denver Post calendar: Submit online.
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...